These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 29629020)

  • 1. Diagnosis, Treatment, and Prevention of Cardiovascular Toxicity Related to Anti-Cancer Treatment in Clinical Practice: An Opinion Paper from the Working Group on Cardio-Oncology of the Korean Society of Echocardiography.
    Kim H; Chung WB; Cho KI; Kim BJ; Seo JS; Park SM; Kim HJ; Lee JH; Kim EK; Youn HJ
    J Cardiovasc Ultrasound; 2018 Mar; 26(1):1-25. PubMed ID: 29629020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardio-Oncology: A Focused Review of Anthracycline-, Human Epidermal Growth Factor Receptor 2 Inhibitor-, and Radiation-Induced Cardiotoxicity and Management.
    Domercant J; Polin N; Jahangir E
    Ochsner J; 2016; 16(3):250-6. PubMed ID: 27660573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling Precision Cardio-Oncology: Using Human-Induced Pluripotent Stem Cells for Risk Stratification and Prevention.
    Perry TR; Roberts ML; Sunkara B; Maddula R; McLeish T; Gomez J; Lucas J; Rayan D; Patel S; Liang M; Bosnjak ZJ; Brown SA
    Curr Oncol Rep; 2021 May; 23(7):77. PubMed ID: 33937943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale for setting up a cardio-oncology unit: our experience at Mayo Clinic.
    Barros-Gomes S; Herrmann J; Mulvagh SL; Lerman A; Lin G; Villarraga HR
    Cardiooncology; 2016 Apr; 2(1):5. PubMed ID: 33530144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An international survey of healthcare providers' knowledge of cardiac complications of cancer treatments.
    Peng J; Rushton M; Johnson C; Brezden-Masley C; Sulpher J; Chiu MG; Graham ID; Dent S
    Cardiooncology; 2019; 5():12. PubMed ID: 32154018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Evolving Design of NIH-Funded Cardio-Oncology Studies to Address Cancer Treatment-Related Cardiovascular Toxicity.
    Minasian L; Dimond E; Davis M; Adhikari B; Fagerstrom R; Fabian C; Floyd J; Unger JM; Douglas PS; Mustian KM; Chow EJ; Lipshultz S; Hundley WG; Armenian S; Ky B
    JACC CardioOncol; 2019 Sep; 1(1):105-113. PubMed ID: 32529192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heartbreaker: Detection and prevention of cardiotoxicity in hematological malignancies.
    Vakilpour A; Lefebvre B; Lai C; Scherrer-Crosbie M
    Blood Rev; 2024 Mar; 64():101166. PubMed ID: 38182490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Concepts in Cardio-Oncology.
    Zagami P; Nicolò E; Corti C; Valenza C; Curigliano G
    Cancer Treat Res; 2023; 188():303-341. PubMed ID: 38175351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer therapy-related cardiac dysfunction and the role of cardiovascular imaging: systemic review and opinion paper from the Working Group on Cardio-Oncology of the Korean Society of Cardiology.
    Cho I; You SC; Cha MJ; Hwang HJ; Cho EJ; Kim HJ; Park SM; Kim SE; Lee YG; Youn JC; Park CS; Shim CY; Chung WB; Sohn IS
    J Cardiovasc Imaging; 2024 Jul; 32(1):13. PubMed ID: 39075626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society.
    Lyon AR; Dent S; Stanway S; Earl H; Brezden-Masley C; Cohen-Solal A; Tocchetti CG; Moslehi JJ; Groarke JD; Bergler-Klein J; Khoo V; Tan LL; Anker MS; von Haehling S; Maack C; Pudil R; Barac A; Thavendiranathan P; Ky B; Neilan TG; Belenkov Y; Rosen SD; Iakobishvili Z; Sverdlov AL; Hajjar LA; Macedo AVS; Manisty C; Ciardiello F; Farmakis D; de Boer RA; Skouri H; Suter TM; Cardinale D; Witteles RM; Fradley MG; Herrmann J; Cornell RF; Wechelaker A; Mauro MJ; Milojkovic D; de Lavallade H; Ruschitzka F; Coats AJS; Seferovic PM; Chioncel O; Thum T; Bauersachs J; Andres MS; Wright DJ; López-Fernández T; Plummer C; Lenihan D
    Eur J Heart Fail; 2020 Nov; 22(11):1945-1960. PubMed ID: 32463967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardio-oncology Part II: the monitoring, prevention, detection and treatment of chemotherapeutic cardiac toxicity.
    O'Hare M; Murphy K; Mookadam F; Sharma A; Lee H
    Expert Rev Cardiovasc Ther; 2015 May; 13(5):519-27. PubMed ID: 25864865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC).
    Čelutkienė J; Pudil R; López-Fernández T; Grapsa J; Nihoyannopoulos P; Bergler-Klein J; Cohen-Solal A; Farmakis D; Tocchetti CG; von Haehling S; Barberis V; Flachskampf FA; Čeponienė I; Haegler-Laube E; Suter T; Lapinskas T; Prasad S; de Boer RA; Wechalekar K; Anker MS; Iakobishvili Z; Bucciarelli-Ducci C; Schulz-Menger J; Cosyns B; Gaemperli O; Belenkov Y; Hulot JS; Galderisi M; Lancellotti P; Bax J; Marwick TH; Chioncel O; Jaarsma T; Mullens W; Piepoli M; Thum T; Heymans S; Mueller C; Moura B; Ruschitzka F; Zamorano JL; Rosano G; Coats AJS; Asteggiano R; Seferovic P; Edvardsen T; Lyon AR
    Eur J Heart Fail; 2020 Sep; 22(9):1504-1524. PubMed ID: 32621569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardio-Oncology Services: rationale, organization, and implementation.
    Lancellotti P; Suter TM; López-Fernández T; Galderisi M; Lyon AR; Van der Meer P; Cohen Solal A; Zamorano JL; Jerusalem G; Moonen M; Aboyans V; Bax JJ; Asteggiano R
    Eur Heart J; 2019 Jun; 40(22):1756-1763. PubMed ID: 30085070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. European Society of Cardiology Core Curriculum for cardio-oncology.
    López-Fernández T; Farmakis D; Ameri P; Asteggiano R; de Azambuja E; Aznar M; Barac A; Bayes-Genis A; Bax JJ; Bergler-Klein J; Boriani G; Celutkiene J; Coats A; Cohen-Solal A; Córdoba R; Cosyns B; Filippatos G; Fox K; Gulati G; Inciardi RM; Lee G; Mamas MA; Novo G; Plummer C; Psyrri A; Rakisheva A; Suter T; Tini G; Tocchetti CG; Toutouzas K; Wilhelm M; Metra M; Lyon AR; Rosano GMC
    Eur J Heart Fail; 2024 Apr; 26(4):754-771. PubMed ID: 38059343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular Imaging in Cardio-Oncology: The Role of Echocardiography and Cardiac MRI in Modern Cardio-Oncology.
    Gambril JA; Chum A; Goyal A; Ruz P; Mikrut K; Simonetti O; Dholiya H; Patel B; Addison D
    Heart Fail Clin; 2022 Jul; 18(3):455-478. PubMed ID: 35718419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale and design of the multidisciplinary team IntervenTion in cArdio-oNcology study (TITAN).
    Pituskin E; Haykowsky M; McNeely M; Mackey J; Chua N; Paterson I
    BMC Cancer; 2016 Sep; 16(1):733. PubMed ID: 27629548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A recommended practical approach to the management of anthracycline-based chemotherapy cardiotoxicity: an opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology.
    Spallarossa P; Maurea N; Cadeddu C; Madonna R; Mele D; Monte I; Novo G; Pagliaro P; Pepe A; Tocchetti CG; Zito C; Mercuro G
    J Cardiovasc Med (Hagerstown); 2016 May; 17 Suppl 1(Suppl 1):S84-92. PubMed ID: 27183529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of dexrazoxane as a cardioprotectant in patients receiving doxorubicin or epirubicin chemotherapy for the treatment of cancer. The Provincial Systemic Treatment Disease Site Group.
    Seymour L; Bramwell V; Moran LA
    Cancer Prev Control; 1999 Apr; 3(2):145-59. PubMed ID: 10474762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic factors in the pathogenesis of cardio-oncology.
    Qi Y; Wei Y; Li L; Ge H; Wang Y; Zeng C; Ma F
    J Transl Med; 2024 Aug; 22(1):739. PubMed ID: 39103883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement.
    Herrmann J; Lenihan D; Armenian S; Barac A; Blaes A; Cardinale D; Carver J; Dent S; Ky B; Lyon AR; López-Fernández T; Fradley MG; Ganatra S; Curigliano G; Mitchell JD; Minotti G; Lang NN; Liu JE; Neilan TG; Nohria A; O'Quinn R; Pusic I; Porter C; Reynolds KL; Ruddy KJ; Thavendiranathan P; Valent P
    Eur Heart J; 2022 Jan; 43(4):280-299. PubMed ID: 34904661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.